Generic Name: Pemazyre ()
Pemazyre Reviews
For Cholangiocarcinoma "My husband has completed 3 rounds of 13.5 mg Pemazyre. He has has a problem with ascites in his abdomen and has been receiving paracentesis 2x per week. Originally he had been averaging 8-10 liters each time during chemotherapy. He completed 6 rounds that failed to help him. He started the Pemazyre and the yield of the paracentesis dropped steadily to 4-6 liters. An encouraging sign!!! He has had a number of side effects. Hair loss, taste loss, ache in his jaw, pain in his limb muscles. During the second week of his 3rd round, a bruise on his calf began to look like blood under the skin and continued to spread causing great pain and eventual hospitalization. Apparently this is a rare and serious side effect and may involve calcium blocking blood vessels and flow. At that same time, a nearly 100% loss of vision has occurred - blind!!! A corner of the retina has lifted and we pray it goes back into place to return his eye sight. Doubtful my husband will continue a low dose."
More about Pemazyre (pemigatinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
- Pemazyre drug information
Professional resources
- Pemazyre prescribing information
- Pemigatinib (AHFS Monograph)
Related treatment guides
- Cholangiocarcinoma
- Myeloid/Lymphoid Neoplasms
